Back
Equity Residential 10K Form
Sell
27
EQR
Equity Residential
Last Price:
$62.56
Seasonality Move:
3.49%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2026-02-15 | 10K | EQR/Equity Residential Annual |
| 2026-01-15 | 10K | EQR/Equity Residential Annual |
| 2025-12-15 | 10K | EQR/Equity Residential Annual |
| 2025-11-15 | 10K | EQR/Equity Residential Annual |
| 2025-10-15 | 10K | EQR/Equity Residential Annual |
| 2025-09-15 | 10K | EQR/Equity Residential Annual |
Receive EQR News And Ratings
See the #1 stock for the next 7 days that we like better than EQR
EQR Financial Statistics
Sales & Book Value
| Annual Sales: | $3.1B |
|---|---|
| Cash Flow: | $330.3M |
| Price / Cash Flow: | 18.89 |
| Annual Sales: | $29.18 |
| Price / Book: | 2.18 |
Profitability
| EPS (TTM): | 2.91460 |
|---|---|
| Net Income (TTM): | $1.2B |
| Gross Margin: | $904.8M |
| Return on Equity: | 10% |
| Return on Assets: | 5.53% |
Equity Residential Earnings Forecast
Key Equity Residential Financial Ratios
-
The Gross Profit Margin over the past 34 years for EQR is 29.53%.
-
The Selling, General & Administrative Expenses for EQR have been equal to 0.00% of Gross Profit Margin.
-
The Interest Expense is 27.26% of Operating Income.
-
The Net Earning history of EQR is 37.60% of Total Revenues.
-
Per Share Earnings over the last 34 years have been positive in 18 years.
Equity Residential Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Residential REITs |
| Sector: | Real Estate |
| Current Symbol: | EQR |
| CUSIP: | 29476L |
| Website: | equityapartments.com |
Debt
| Debt-to-Equity Ratio: | 0.8 |
|---|---|
| Current Ratio: | 0.04 |
| Quick Ratio: | 0.03 |
Price-to-Earnings
| Trailing P/E Ratio: | 21.48 |
|---|---|
| Forward P/E Ratio: | 41.4 |
EQR Technical Analysis vs Fundamental Analysis
Sell
27
Equity Residential (EQR)
is a Sell
Is Equity Residential a Buy or a Sell?
-
Equity Residential stock is rated a SellThe current Equity Residential [EQR] share price is $63.05. The Score for EQR is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.